A multi-centre, retrospective real world study on the use of renin-angiotensin-aldosterone system inhibitors (RAASi) management in patients treated for chronic kidney disease alongside heart failure and/or type 2 diabetes mellitus. (SoMoR – UK (Study of Management of RAASi in UK))

28/03/2018
28/03/2018
EU PAS number:
EUPAS23376
Study
Planned

ENCePP Code of conduct

No
Data sources

Data sources (types)

Other

Data sources (types), other

Data will be extracted from the electronic Patient Administration System (PAS), service databases and electronic (or paper) medical notes by the NHS direct clinical care teams or CRO researcher.
Use of a Common Data Model (CDM)

CDM mapping

No
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

No